English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 848305      Online Users : 947
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/5271


    Title: PDGFRA one nucleotide deletion: A novel mutation of systemic mastocytosis associated with chronic myelomonocytic leukemia
    Authors: Wu, YY;Nieh, SW;Chen, LT;Chan, H;Sheu, LF;Chao, TY;Chen, YC
    Contributors: National Institute of Cancer Research
    Abstract: Background: The mast cell is a common tissue cell located in connective tissue around blood vessels and beneath the capsular tissues of most organs. Uncontrolled proliferation can lead to mast cell disease, which may have different clinical presentation depending on site of primary involvement. Recently, a point mutation in the c-kit receptor gene, Asp816Val (D816V), was shown to activate c-kit, via ligand-independent receptor autophosphorylation resulting in uncontrolled mast cell proliferation. Fusion gene involving Fip1-like 1(FIPL1L1) and plateletderived growth factor receptorα (PDGFRA) was identified in hypereosinophilic syndrome (HES) and mast cell disease. These mutations might have quite different treatment response to imatinib mesylate. Case Report: A 71-year-old man presented with intractable ascites, hepatosplenomegaly, and skin ecchymosis change. Laboratory tests showed leukocytosis, monocytosis, and anemia. Histopathological examination of bone marrow, liver, skin, and ascites all showed spindle-shaped mast cells infiltration. Gene mutation analysis revealed one nucleotide deletion in PDGFRA exon18; the frame-shift generating a new mutated protein. The patient was treated with hydroxyurea. His ascites and leukocytosis were under controlled. Conclusions: Systemic mastocytosis should be considered as one cause of ascites, especially in those patients with unexplained hepatomegaly and splenomegaly. Genetic analysis is crucial in this kind of cases in order to determine the treatment strategy and evaluate patients' prognosis.
    Date: 2008
    Relation: American Journal of Case Reports. 2008;9:10-14.
    Link to: http://www.journals.indexcopernicus.com/abstracted.php?level=5&icid=690770
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=78249235645
    Appears in Collections:[陳立宗] 期刊論文
    [詹宗晃(2000-2008)] 期刊論文

    Files in This Item:

    File Description SizeFormat
    SCP78249235645.pdf714KbAdobe PDF465View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback